Everolimus Oral Product

DRUG2 trials

Sponsors

University of Pennsylvania, Gynaecologisch Oncologisch Centrum Zuid

Conditions

LymphangioleiomyomatosisRecurrent Ovarian CancerSignal Transduction Pathway DeregulationTherapy-Associated CancerTuberous Sclerosis Complex

Phase 1

Safety of Simvastatin in LAM and TSC

CompletedNCT02061397

University of PennsylvaniaLymphangioleiomyomatosis, Tuberous Sclerosis Complex

Start: 2014-03-31End: 2019-12-13Updated: 2020-08-25

Phase 2

Signal TrAnsduction Pathway Activity Analysis in OVarian cancER

RecruitingNCT03458221

Gynaecologisch Oncologisch Centrum ZuidRecurrent Ovarian Cancer, Signal Transduction Pathway Deregulation, Therapy-Associated Cancer

Start: 2023-01-31End: 2026-10-01Target: 148Updated: 2023-04-18